Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2021

Feb 17, 2021

30016_dirs_2021-02-17_c8fda088-69a6-4086-84ec-f8b7bd58770c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14

Reporting Person: Underberg Sharon E. (SVP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-14 Common Stock M 483 Acquired 1386 Direct
2021-02-14 Common Stock M 217 Acquired 1603 Direct
2021-02-14 Common Stock F 208 $544.08 Disposed 1395 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-14 Non-Qualified Stock Option (right-to-buy) $544.08 A 5119 Acquired 2031-02-13 Common Stock (5119) Direct
2021-02-14 Incentive Stock Option (right-to-buy) $544.08 A 183 Acquired 2031-02-13 Common Stock (183) Direct
2021-02-14 Restricted Stock Unit $ A 551 Acquired Common Stock (551) Direct
2021-02-14 Restricted Stock Unit $ M 453 Disposed Common Stock (453) Direct
2021-02-14 Restricted Stock Unit $ M 217 Disposed Common Stock (217) Direct

Footnotes

F1: Includes a total of 29 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2020 and December 31, 2020.

F2: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.

F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.

F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F8: Not applicable.